(3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[1-[(4-methyl-3-pyridinyl)oxy]ethyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol

C27H39NO2 — CID 170306577

IUPAC(3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[1-[(4-methyl-3-pyridinyl)oxy]ethyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
SMILESCc1ccncc1OC(C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
InChIInChI=1S/C27H39NO2/c1-17-11-14-28-16-25(17)30-18(2)22-7-8-23-21-6-5-19-15-20(29)9-12-26(19,3)24(21)10-13-27(22,23)4/h5,11,14,16,18,20-24,29H,6-10,12-13,15H2,1-4H3/t18?,20-,21-,22+,23-,24-,26-,27+/m0/s1
InChIKeyZGHRTWAFNHVPSM-RUYHLHGNSA-N
MW409.61 g/mol
LogP6.10
Rot. Bonds3

About (3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[1-[(4-methyl-3-pyridinyl)oxy]ethyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol

(3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[1-[(4-methyl-3-pyridinyl)oxy]ethyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol (PubChem CID 170306577) has the molecular formula C27H39NO2 and a molecular weight of 409.61 g/mol. Its IUPAC name is (3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[1-[(4-methyl-3-pyridinyl)oxy]ethyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol.

Molecular Properties

Compound Name(3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[1-[(4-methyl-3-pyridinyl)oxy]ethyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
PubChem CID170306577
Molecular FormulaC27H39NO2
Molecular Weight409.61 g/mol
Exact Mass409.30
IUPAC Name(3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[1-[(4-methyl-3-pyridinyl)oxy]ethyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
SMILESCc1ccncc1OC(C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
InChIInChI=1S/C27H39NO2/c1-17-11-14-28-16-25(17)30-18(2)22-7-8-23-21-6-5-19-15-20(29)9-12-26(19,3)24(21)10-13-27(22,23)4/h5,11,14,16,18,20-24,29H,6-10,12-13,15H2,1-4H3/t18?,20-,21-,22+,23-,24-,26-,27+/m0/s1
InChIKeyZGHRTWAFNHVPSM-RUYHLHGNSA-N
XLogP6.10
TPSA42.35 Ų
H-Bond Donors1
H-Bond Acceptors3
Rotatable Bonds3
Heavy Atoms30
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500409.61
LogP ≤ 56.10
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[1-[(4-methyl-3-pyridinyl)oxy]ethyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[1-[(4-methyl-3-pyridinyl)oxy]ethyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol?
The IUPAC name of (3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[1-[(4-methyl-3-pyridinyl)oxy]ethyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol (CID 170306577) is (3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[1-[(4-methyl-3-pyridinyl)oxy]ethyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol.
What is the SMILES notation for (3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[1-[(4-methyl-3-pyridinyl)oxy]ethyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol?
The canonical SMILES for (3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[1-[(4-methyl-3-pyridinyl)oxy]ethyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol is Cc1ccncc1OC(C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C.
What is the InChIKey of (3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[1-[(4-methyl-3-pyridinyl)oxy]ethyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol?
The InChIKey is ZGHRTWAFNHVPSM-RUYHLHGNSA-N. The full InChI is InChI=1S/C27H39NO2/c1-17-11-14-28-16-25(17)30-18(2)22-7-8-23-21-6-5-19-15-20(29)9-12-26(19,3)24(21)10-13-27(22,23)4/h5,11,14,16,18,20-24,29H,6-10,12-13,15H2,1-4H3/t18?,20-,21-,22+,23-,24-,26-,27+/m0/s1.
What are the key properties of (3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[1-[(4-methyl-3-pyridinyl)oxy]ethyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol?
(3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[1-[(4-methyl-3-pyridinyl)oxy]ethyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol has a molecular weight of 409.61 g/mol, XLogP of 6.10, 3 rotatable bonds, 1 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for (3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[1-[(4-methyl-3-pyridinyl)oxy]ethyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol is sourced from PubChem (CID 170306577), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).